GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Shapuaisi Pharmaceutical Co Ltd (SHSE:603168) » Definitions » Ending Cash Position

Zhejiang Shapuaisi Pharmaceutical Co (SHSE:603168) Ending Cash Position : ¥108.3 Mil (As of Mar. 2025)


View and export this data going back to 2014. Start your Free Trial

What is Zhejiang Shapuaisi Pharmaceutical Co Ending Cash Position?

Zhejiang Shapuaisi Pharmaceutical Co's Ending Cash Position for the quarter that ended in Mar. 2025 was ¥108.3 Mil.

Zhejiang Shapuaisi Pharmaceutical Co's quarterly Ending Cash Position declined from Sep. 2024 (¥195.5 Mil) to Dec. 2024 (¥82.8 Mil) but then increased from Dec. 2024 (¥82.8 Mil) to Mar. 2025 (¥108.3 Mil).

Zhejiang Shapuaisi Pharmaceutical Co's annual Ending Cash Position declined from Dec. 2022 (¥525.1 Mil) to Dec. 2023 (¥355.7 Mil) and declined from Dec. 2023 (¥355.7 Mil) to Dec. 2024 (¥82.8 Mil).

Zhejiang Shapuaisi Pharmaceutical Co Ending Cash Position Historical Data

The historical data trend for Zhejiang Shapuaisi Pharmaceutical Co's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Shapuaisi Pharmaceutical Co Ending Cash Position Chart

Zhejiang Shapuaisi Pharmaceutical Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 106.78 138.52 525.06 355.67 82.79

Zhejiang Shapuaisi Pharmaceutical Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 197.28 151.17 195.46 82.79 108.28

Zhejiang Shapuaisi Pharmaceutical Co Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Zhejiang Shapuaisi Pharmaceutical Co's Ending Cash Position for the fiscal year that ended in Dec. 2024 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=355.666+-272.879
=82.8

Zhejiang Shapuaisi Pharmaceutical Co's Ending Cash Position for the quarter that ended in Mar. 2025 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=82.787+25.492
=108.3

Zhejiang Shapuaisi Pharmaceutical Co Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Zhejiang Shapuaisi Pharmaceutical Co's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Zhejiang Shapuaisi Pharmaceutical Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Shapuaisi Pharmaceutical Co Ltd (SHSE:603168) » Definitions » Ending Cash Position
Comparable Companies
SZSE:301331 SZSE:000153 SHSE:603079 SHSE:600080 SZSE:002412 SZSE:301520 SZSE:002940 SHSE:600513 SZSE:300534 SZSE:300452 ZTS XTER:MRK LSE:HLN NSE:SUNPHARMA TSE:4502 XSWX:GALD XSWX:SDZ NSE:DIVISLAB HKSE:03692 XTAE:TEVA
Traded in Other Exchanges
N/A
Address
No. 1588 Xinming Road, Economic Development Zone, Zhejiang Province, Pinghu, CHN, 314200
Website
https://www.zjspas.com
Zhejiang Shapuaisi Pharmaceutical Co Ltd is a China based pharmaceutical company. It is engaged in drug research and development, production and operation. The product portfolio of the company includes oral solutions, eye drops, tablets, hard capsules, suppositories, granules, raw materials dosage forms such as medicines, rinsing agent and mixture, and others. The company operates pharmaceutical manufacturing companies, pharmaceutical sales company, pharmaceutical retail company and pharmaceutical research institute. The products offered by the company are sold in China and are also exported to the other countries.
Executives
Huang Ming Xiong Directors, senior managers
Wu Jian Guo Director
Xu Hong Sheng senior management
Hu Zheng Guo Director
Ge Sheng Fang Director
Feng Xiao Supervisors
Chen De Kang Director

Zhejiang Shapuaisi Pharmaceutical Co Headlines

No Headlines